Log In Sign up
The largest database of trusted experimental protocols

Deferoxamine mesylate

Manufactured by Thermo Fisher Scientific
Visit Supplier
Sourced in Belgium

Deferoxamine mesylate is an iron chelating agent. It binds to and removes excess iron from the body.

Automatically generated - may contain errors

Lab products found in correlation

Doxorubicin, by Thermo Fisher Scientific (1 mentions) Vincristine, by Thermo Fisher Scientific (1 mentions) Gemcitabine, by Thermo Fisher Scientific (1 mentions) Celltiter glo 2, by Promega (1 mentions) Sn 38, by Selleck Chemicals (1 mentions) Ku 60019, by Selleck Chemicals (1 mentions) Sorafenib, by Thermo Fisher Scientific (1 mentions) Cisplatin, by Merck Group (1 mentions) Prism software, by GraphPad (1 mentions) Acetone, by Thermo Fisher Scientific (1 mentions) Acryloyl chloride, by Thermo Fisher Scientific (1 mentions) Deuterium oxide, by Thermo Fisher Scientific (1 mentions) Iron 3 chloride hexahydrate, by Thermo Fisher Scientific (1 mentions) Mtt assay kit, by Thermo Fisher Scientific (1 mentions) 4 4 azobis 4 cyanovaleric acid acva, by Thermo Fisher Scientific (1 mentions) Curcumin, by Thermo Fisher Scientific (1 mentions)

2 protocols using deferoxamine mesylate

1

High-throughput Drug Screening in HepG2 Cells

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2 or HB214 (1500 cells/well) was seeded on a 384 well plate in 30 μl. Drugs were added after 24 h. Cell Titer Glo (CTG) viability assay was conducted after 72 h of drug treatment. Briefly, CellTiter-Glo 2.0 (#G9243 Promega) was added to each well in a 1:1 v/v ratio. Plates were then covered to keep from light and incubated at RT on an orbital shaker at 150 RPM for 30 mins. After the incubation, plate was read on a synergy H4 plate reader for luminescence. Dose effect curves for each drug were calculated using Prism software, version 9 (GraphPad). For drug combinations, responses were analyzed using SynergyFinder2.050 (link). Drugs used include cisplatin (#479036-5 G, Sigma Aldrich), gemcitabine (#AC456890010, Fisher Scientific), vincristine (#AAJ60907MA, Fisher Scientific), triapine (#50-136-4826, Fisher Scientific), MK1775 (#M4102, LKT laboratories, Saint Paul, Minnesota), doxorubicin (#BP25161, Fisher Scientific), sorafenib (#NC0749948, Fisher Scientific), SN-38 (#S4908-50MG, Selleck Chemicals, Harris County, Texas), deferoxamine mesylate (#AC461770010, Acros Organics, Geel, Belgium), KU60019 (#S1570, Selleck Chemicals). All concentrations were seeded in triplicate and the experiment was repeated three times. Significance was determined using the Extra Sum of Squares f test.
Brown A., Pan Q., Fan L., Indersie E., Tian C., Timchenko N., Li L., Hansen B.S., Tan H., Lu M., Peng J., Pruett-Miller S.M., Yu J., Cairo S, & Zhu L. (2023). Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse. Communications Biology, 6, 249.
+ Open protocol
+ Expand
2

Synthesis and Characterization of Multifunctional Theranostic Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
2-methacryloyloxyethyl phosphorylcholine (MPC, 97%), L-serine (≥99.5%), sodium phosphotungstate hydrate, sodium carbonate (≥99.5%), TWEEN 80, 4-cyano-4-(phenylcarbonothioylthio) pentanoic acid (CPD, 97%), and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldric. HPLC-grade tetrahydrofuran and chloroform, acetone, deuterium oxide, and deferoxamine mesylate (DFO, 95%) were purchased from Acros Organics. 4,4’-azobis (4-cyanovaleric acid) (ACVA, 98%), curcumin (95%), acryloyl chloride (55%), and iron (III) chloride hexahydrate were purchased from Alfa Aesar. Nanosep centrifugal devices with Omega membrane (3K MWCO) were purchased from Pall Corporation. Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum (FBS), and (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) (MTT) assay kits were purchased from Thermo Fisher Scientific. Dialysis membranes (8K MWCO) were purchased from Spectrum Laboratories, Inc. Copper mesh was purchased from Ted Pella. Copper sulfate was purchased from Showa Co., Ltd. MDA-MB-231 breast cancer cells were purchased from the Bioresource Collection and Research Center in Taiwan. Deionized water with a minimum resistivity of 18.0 MΩ·m was used in experiments.
Chen P.C., Lai J.J, & Huang C.J. (2021). Bio-Inspired Amphoteric Polymer for Triggered-Release Drug Delivery on Breast Cancer Cells Based on Metal Coordination.. ACS applied materials & interfaces, 13(22), 25663-25673.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!